Onconetix, Inc. Share Price
NASDAQ: ONCO | Micro CapOnconetix, Inc. Stock Performance
Onconetix, Inc. Share Price Today
As of 30 October 2026, Onconetix, Inc.'s share price is $0.57. The stock opened at $0.60, compared to its previous close of $0.59. During today's trading session, Onconetix, Inc.'s share price traded between $0.55 and $0.64, with an average price of $0.59. Over the past 52 weeks, the stock has recorded a high of $6.71 and a low of $0.09. In terms of performance, Onconetix, Inc.'s share price has declined by 17.63% over the last six months and is down 85.07% on a year-on-year basis.
Onconetix, Inc. Share Price Chart
Onconetix, Inc. Quarterly Profit & Loss
All figures in USD
Onconetix, Inc. Annual Profit & Loss
All figures in USD
About Onconetix, Inc.
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. The company owns Proclarix, an in vitro diagnostic test for prostate cancer, approved for sale in the European Union. Additionally, it is focused on marketing Proclarix in the U.S. as a lab-developed product. Onconetix operates in one segment: commercial. Geographically, the company generates maximum revenue from Switzerland and the rest from the United Kingdom.
Onconetix, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $0.77 | $0.55 | -29.09% |
Sep 2026 | $0.72 | $0.78 | +21.79% |
Aug 2026 | $0.80 | $0.64 | -15.61% |
Jul 2026 | $1.04 | $0.76 | -34.83% |
Jun 2026 | $1.18 | $1.16 | -3.73% |
May 2026 | $0.66 | $1.21 | +75.40% |
Apr 2026 | $1.46 | $0.69 | -54.05% |
Mar 2026 | $0.65 | $1.50 | +126.52% |
Feb 2026 | $1.39 | $0.66 | -55.41% |
Jan 2026 | $1.69 | $1.48 | -7.50% |
Dec 2025 | $2.70 | $1.60 | -41.50% |
Nov 2025 | $3.26 | $2.73 | -27.84% |